Tenaya Therapeutics
TNYA
50 hedge funds and large institutions have $440M invested in Tenaya Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 4 closing their positions.
144% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 9
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
6% more funds holding
Funds holding: 47 → 50 (+3)
4.81% more ownership
Funds ownership: 85.65% → 90.46% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
34% less capital invested
Capital invested by funds: $668M → $440M (-$228M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.73M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.67M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.68M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.61M |
| 2 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$269K |
| 3 |
Morgan Stanley
New York
|
-$226K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$35.4K |
| 5 |
Citigroup
New York
|
-$34.1K |
TNYA Hedge Fund Activity: Q1 2022 in Review
50 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q1 2022, worth a combined $440M — down 34% from $668M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TNYA positions and 4 closed out — a net gain of 3 holders — while 22 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $6.73M. The largest seller was Deep Track Capital, cutting an estimated $2.61M.
- 50 institutional investors held Tenaya Therapeutics (TNYA) as of Q1 2022, up from 47 in Q4 2021.
- Funds reported $440M of Tenaya Therapeutics stock for Q1 2022, down 34% quarter-over-quarter.
- 7 funds opened new Tenaya Therapeutics positions in Q1 2022 and 4 closed out, a net change of +3 holders.
- The largest Tenaya Therapeutics buyer in Q1 2022 was BlackRock, an estimated $6.73M added.
- The largest Tenaya Therapeutics seller in Q1 2022 was Deep Track Capital, an estimated $2.61M sold.
Based on aggregated 13F filings for Q1 2022.